Galectin Therapeutics


Galectin Therapeutics Stock Quote
$2.77 $0.16 6.1%
Price as of August 13, 2020, 10:30 a.m. EDT View Interactive GALT Charts

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

Interactive Chart

News & Analysis: Galectin Therapeutics


Market Moves

Why Galectin Therapeutics Inc. Shares Jumped

Galectin shares soar following the company's dosing of its first patient in a second phase 1 cohort. Here's what shareholders should really be watching.

Why Galectin Therapeutics, Inc. Shares Soared

Galectin sets the date for the release of its phase 1 study data on GR-MD-02 for nonalcoholic steatohepatitis. Find out what shareholders should really be waiting for.